Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionKestra Advisory Services, LLC
Latest Disclosed Ownership93,229 shares
Latest Disclosed Value $ 32,802,788
Kestra Advisory Services, LLC reports 1.43% decrease in ownership of AMGN / Amgen Inc.

On April 30, 2026 - Kestra Advisory Services, LLC filed a 13F-HR form disclosing ownership of 93,229 shares of Amgen Inc. (CH:AMGN) valued at $32,802,788 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 94,577 shares of Amgen Inc.. This represents a change in shares of -1.43% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F AMGEN COM 031162100 93,229 -1,348 -1.43 32,803 5.96 0.1241
2026-02-13 2025-12-31 13F AMGEN COM 031162100 94,577 -7,647 -7.48 30,956 7.31 0.1275
2025-11-14 2025-09-30 13F AMGEN COM 031162100 102,224 11,175 12.27 28,848 13.48 0.1320
2025-08-15 2025-06-30 13F AMGEN COM 031162100 91,049 2,792 3.16 25,422 -7.55 0.1239
2025-05-14 2025-03-31 13F AMGEN COM 031162100 88,257 -2,263 -2.50 27,496 16.54 0.1331
2025-02-10 2024-12-31 13F AMGEN COM 031162100 90,520 -17,654 -16.32 23,593 -32.31 0.1289
2024-11-13 2024-09-30 13F AMGEN COM 031162100 108,174 -3,466 -3.10 34,855 -0.08 0.1920
2024-08-14 2024-06-30 13F AMGEN COM 031162100 111,640 31,058 38.54 34,882 52.25 0.1949
2024-05-15 2024-03-31 13F AMGEN COM 031162100 80,582 16,407 25.57 22,911 23.96 0.1536
2024-02-14 2023-12-31 13F AMGEN COM 031162100 64,175 6,303 10.89 18,484 18.84 0.1498
2023-11-13 2023-09-30 13F AMGEN COM 031162100 57,872 995 1.75 15,554 23.17 0.1529
2023-08-11 2023-06-30 13F AMGEN COM 031162100 56,877 16,444 40.67 12,628 29.19 0.1264
2023-05-12 2023-03-31 13F AMGEN COM 031162100 40,433 -15,477 -27.68 9,775 -33.44 0.1060
2023-01-31 2022-12-31 13F AMGEN COM 031162100 55,910 -9,718 -14.81 14,684 104,785.71 0.1305
2022-11-01 2022-09-30 13F/A-1 AMGEN COM 031162100 65,628 1,963 3.08 15 -6.67 0.1583
2022-11-01 2022-09-30 13F AMGEN COM 031162100 65,628 1,963 14,793 0.1583
2022-08-12 2022-06-30 13F AMGEN COM 031162100 63,665 21,668 51.59 15 50.00 0.1592
2022-07-20 2022-03-31 13F/A-1 AMGEN COM 031162100 41,997 -8,361 -16.60 10 -9.09 0.1058
2022-04-26 2022-03-31 13F AMGEN COM 031162100 41,997 -8,361 10,156 0.1058
2022-07-25 2021-12-31 13F/A-1 AMGEN COM 031162100 50,358 1,933 3.99 11 10.00 0.1147
2022-01-20 2021-12-31 13F AMGEN COM 031162100 50,358 1,933 11,329 0.1147
2022-07-25 2021-09-30 13F/A-1 AMGEN COM 031162100 48,425 2,031 4.38 10 -9.09 0.1030
2021-10-19 2021-09-30 13F AMGEN COM 031162100 48,425 2,031 10,298 0.1030
2022-07-26 2021-06-30 13F/A-1 AMGEN COM 031162100 46,394 -1,014 -2.14 11 0.00 0.1284
2021-07-28 2021-06-30 13F AMGEN COM 031162100 46,394 -1,014 11,309 0.1284
2022-07-27 2021-03-31 13F/A-1 AMGEN COM 031162100 47,408 -176 -0.37 12 10.00 0.1497
2021-05-10 2021-03-31 13F AMGEN COM 031162100 47,408 -176 11,796 0.1497
2022-07-28 2020-12-31 13F/A-1 AMGEN COM 031162100 47,584 11,323 31.23 11 -100.00 0.1253
2021-01-20 2020-12-31 13F AMGEN COM 031162100 47,584 11,323 10,810 0.1253
2022-07-29 2020-09-30 13F/A-1 AMGEN COM 031162100 36,261 36,261 9,183,000 0.1714
2020-11-12 2020-09-30 13F AMGEN COM 031162100 36,261 36,261 9,183 0.1714
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.